Contact

    Cognate Insights

    Cognate BioServices Announces Major Expansion of Manufacturing Facilities in US and Europe
    featured

    Cognate BioServices Announces Major Expansion of Manufacturing Facilities in US and Europe

    Cognate BioServices, Inc., the premier commercial-ready, global CDMO in the Cell and Gene Therapy industry, announced today its plans to expand cell and gene therapy manufacturing capacity, laboratory space, warehousing capabilities, and increase office support at its...
    Read More
    [null]

    Media Inquiries

    Cognate’s team is available to discuss our recent news further.

    Contact
    Cognate BioServices Announces Major Expansion of Manufacturing Facilities in US and Europe

    Cognate BioServices Announces Major Expansion of Manufacturing Facilities in US and Europe

    Cognate BioServices Announces Major Expansion of Manufacturing Facilities in US and Europe

    Cognate BioServices, Inc., the premier commercial-ready, global CDMO in the Cell and Gene Therapy industry, announced today its plans to expand cell and gene therapy... Read More
    Cognate BioServices, the Leading Biologics CDMO, Selects L7 Informatics to Implement L7|ESP for Integrated Manufacturing and Lab Operations

    Cognate BioServices, the Leading Biologics CDMO, Selects L7 Informatics to Implement L7|ESP for Integrated Manufacturing and Lab Operations

    Cognate BioServices, the Leading Biologics CDMO, Selects L7 Informatics to Implement L7|ESP for Integrated Manufacturing and Lab Operations

    L7 Informatics announced that it has partnered with Cognate BioServices, Inc., the premier commercial-ready CDMO in the Cell & Gene Therapy industry, to deploy L7|ESP... Read More
    Cognate BioServices Names Tom Pamukcoglu as VP, Global Head of Quality

    Cognate BioServices Names Tom Pamukcoglu as VP, Global Head of Quality

    Cognate BioServices Names Tom Pamukcoglu as VP, Global Head of Quality

    MEMPHIS, Tennessee, November 2, 2020 /PRNewswire/ -- Cognate BioServices, Inc., the premier commercial-ready CDMO in the Cell & Gene Therapy industry, announced today the... Read More
    J. Kelly Ganjei to speak at the Morgan Stanley Global Healthcare Conference

    J. Kelly Ganjei to speak at the Morgan Stanley Global Healthcare Conference

    J. Kelly Ganjei to speak at the Morgan Stanley Global Healthcare Conference

    Join Cognate's CEO, J. Kelly Ganjei, as he speaks at the upcoming Morgan Stanley Global Healthcare Conference - Thursday, September 17 at 2:45pm EDT.  ... Read More
    J. Kelly Ganjei of Cognate announced as an Entrepreneur Of The Year® 2020 Southeast Award Finalist

    J. Kelly Ganjei of Cognate announced as an Entrepreneur Of The Year® 2020 Southeast Award Finalist

    J. Kelly Ganjei of Cognate announced as an Entrepreneur Of The Year® 2020 Southeast Award Finalist

    Ernst & Young LLP (EY US) today announced that J. Kelly Ganjei, CEO of Cognate BioServices, Inc. was named an Entrepreneur Of The Year® 2020 Southeast Award finalist. Now in... Read More
    Cognate Reveals New Brand Identity with Redesigned Logo and Website

    Cognate Reveals New Brand Identity with Redesigned Logo and Website

    Cognate Reveals New Brand Identity with Redesigned Logo and Website

      Read More
    Join Cognate BioServices at the CAR-TCR Summit in Boston

    Join Cognate BioServices at the CAR-TCR Summit in Boston

    Join Cognate BioServices at the CAR-TCR Summit in Boston

    September 14-17, 2020 Boston, MA Read More
    No More Posts